FibroGen (MEX:FGEN) Cash Flow from Discontinued Operations : MXN0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is FibroGen Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

FibroGen's cash flow from discontinued operations for the three months ended in Jun. 2024 was MXN0 Mil. It means FibroGen received MXN0 Mil from the sale of part of business quarterly. FibroGen's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Jun. 2024 was MXN0 Mil.

FibroGen Cash Flow from Discontinued Operations Historical Data

The historical data trend for FibroGen's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen Cash Flow from Discontinued Operations Chart

FibroGen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow from Discontinued Operations

Get a 7-Day Free Trial

FibroGen Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial															-	-	-	-	-

FibroGen Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

FibroGen Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of FibroGen's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroGen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (MEX:FGEN) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

FGEN:USA 0IL8:UK 1FG:Germany

Address

409 Illinois Street, San Francisco, CA, USA, 94158

Website

https://www.fibrogen.com

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.